Seroprevalence of hepatitis b virus infection and associated factors among prison inmates in state of mato grosso do sul, Brazil;Soroprevalência e fatores associados à infecção pelo vírus da hepatite b em população encarcerada no estado do mato grosso do sul, Brasil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 5, 2010, Pages 512-515

  Stief, Alcione Cavalheiro Faro ^a   Martins, Regina Maria Bringel ^b   de Andrade, Sônia Maria Oliveira ^a   Pompilio, Mauricio Antonio ^a   Fernandes, Sonia Maria ^a   Murat, Paula Guerra ^a   Mousquer, Gina Jonasson ^a   Teles, Sheila Araújo ^c   Camolez, Graciele Rodrigues ^a   Francisco, Roberta Barbosa Lopes ^d   Motta Castro, Ana Rita Coimbra ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c Federal University of Goiânia   (Brazil)

^d Central Public Health Laboratory   (Brazil)

Author keywords

Associated factors; Hepatitis B; Prevalence; Prisoners

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; ILLICIT DRUG; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA; HEPATITIS VACCINE;

ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; BRAZIL; DRUG USE; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; INFECTION RATE; INFECTION SENSITIVITY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POLYMERASE CHAIN REACTION; PRISONER; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; SURGERY; VACCINATION; DATA ANALYSIS; DEMOGRAPHY; INTERVIEW; MULTIVARIATE ANALYSIS; PRISON; QUESTIONNAIRE; SEROLOGY; SOCIAL ASPECT; VIRUS CARRIER;

HEPATITIS B VIRUS;

EID: 81455136149     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000500008     Document Type: Article

References (29)

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373:582-592.
2. Viana S, Parana R, Moreira RC, Compri AC, Macedo V. High prevalence of hapatitis B vírus and hepatitis D virus in the western Brasilian Amazon. Am J Trop Med Hyg 2005; 73:808-814.
3. Souto FJD. Distribuição da hepatite B no Brasil: atualização do mapa epidemiológico e proposições para seu controle. Gastroenterol Endosc Digest 1999; 18:143-150.
4. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000; 18:17-19.
5. Weild AR, Gill ON, Bennett D, Levingstone SJM, Parry JV, Curran. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000; 3:121-126.
6. Javadi AA, Avijgan M, Hafizi M. Prevalence of HBV and HCV infections and associated risk factors in addict prisoners. Iranian J Publ Health 2006; 35:33-36.
7. Decker MD, Vaugh WA, Brodie JS, Hutcheson RH, Schaffner W. Seroepidemiology of hepatitis B in Tenessee prisoners. J Infect Dis 1984; 150:450-459.
8. Martelli CMT, Andrade ALLS, Cardoso DDP, Sousa LCS, Silva SA, Sousa MA, et al. Soroprevalência e fatores de risco para a infecção pelo vírus da hepatite B pelos marcadores AgHBs e anti-HBs em prisioneiros e primodoadores de sangue. Rev Saude Publica 1990; 24:270-276.
9. Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997; 26:1359-1366.
10. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: results of a national cross sectional survey. BMJ 2000; 321:78-82.
11. Catalan-Soares BC, Almeida RTP, Carneiro-Proietti ABF. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B vírus (HBV) e C (HCV), do Treponema pallidum and Trypanosoma cruzi entre presidiários em Manhuaçu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 2000; 33:27-30.
12. Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, et al. Correlates of HIV, HVB, and HCV infections in a prison inmate population: results form a multicentre study in Italy. J Med Virol 2005; 76:311-317.
13. Thomas AR, Keene WE, Cieslak PR. Seroprevalence of hepatitis B and C in juvenile detention entrants, Oregon, 1994-1996. J Adolesc Health 2005; 37:411-414.
14. Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D, et al. Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervetion. AIDS Behav 2008; 12 (suppl 4): S17-24.
15. Coelho HC, Oliveira SAN, Miguel JC, Oliveira MLA, Figueiredo JFC, Perdoná GC, et al. Soroprevalência da infecção pelo vírus da hepatite B em uma prisão brasileira. Rev. Bras. Epidemiol 2009; 12:124-131.
16. Awofeso N. Hepatitis B vaccination in prisons. Bull World Health Organ 2002; 80:569-574.
17. Macalino EG, Viahov D, Sanford-Colby S, Patel S, Sabin K, Salas C. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 2004; 94:1218-1223.
18. Osti NM, Pestana de Castro AF, Ricci LC. Research of antigen and antibodies from retroviruses, CMV and HBV among prisoners of the penitentiary complex of the region of Campinas, SP, Brazil. Rev Inst Med Trop São Paulo 1998; 40:209-213.
19. Motta-Castro ARC, Martins RMB, Yoshida CFT, Teles AS, Paniago AM, Lima KMB, et al. Hepatitis B virus infection in isolated Afro-Brazilian communities. J Med Virol 2005; 77:188-193.
20. Leila MMB, Pereira CMT, Martelli EMH, Ulisses R, Montarroyos MLC, Lima MRA, et al. Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factor Differences among Three Regions in Brazil. Am J Trop Med Hyg 2009; 81:240-247.
21. Motta-Castro ARC, Yoshida CFT, Lemos CRS, Oliveira JM, Cunha RV, Lewis-Ximenes LL, et al. Seroprevalence of hepatitis B virus infection among an Afro-descendent community in Brazil. Mem Inst Oswaldo Cruz 2003; 98:13-17.
22. Souza MG, Passos ADC, Machado AA, Figueiredo JFC, Esmeraldino LE. HIV and hepatitis B virus co-infection: prevalence and risk factors. Rev Soc Bras Med Trop 2004; 37:391-395.
23. Matos MAD, Reis NRS, Klozlowki AG, Teles AS, Motta-Castro ARC, Mello FCA, et al. Epidemiological study of hepatitis A, B and C in the largest Afro-Brazilian isolated community. Trans R Soc Trop Med Hyg 2009; 103:899-905.
24. Human Rights Watch (HRW). O Brasil atrás das grades, 1998. Disponível em: . Acesso em: 15 de agosto 2008.
25. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah, Adu-Gyamfi C, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: a national multicenter study. BMC Infect Dis 2008; 7:33.
26. Matos MA, Martins RMB, França DDS, Pessoni GC, Ferreira RC, Matos MAD, et al. Epidemiology of hepatitis B infection in truck drivers in Brazil, South America. Sex Transm Infect 2008; 84:386-389.
27. Rossi D, Radulich G, Muzzio E, Naveira J, Sosa-Estani S, Rey J, et al. Multiple infections and associated risk factors among non-injecting cocaine users in Argentina. Cad Saude Publica 2008; 24:965-974.
28. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates os prevalent HIV, hepatitis B virus, and hepatitis C virus infection among non-injecting heroin users. J Acquir Immune Defic Syndr 2002; 30(suppl 4):448-456.
29. Rosenblum L, Darrow W, Witte J, Cohen J, French J, Sikes K, et al. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis Delta virus infection in female prostitutes in the United States. JAMA 1992; 267:2477-2481.